Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Cookson

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
BJU International|November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosisFrancesco Soria, Peter C Black, Adrian S Fairey, et al.
The Journal of Urology|August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder CancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
Lancet (London, England)|July 7, 2018
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trialDipen J Parekh, Isildinha M Reis, Erik P Castle, et al.
The Journal of Urology|September 25, 2019
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year FollowupVivek Venkatramani, Isildinha M Reis, Erik P Castle, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2Alan H Bryce, E David Crawford, Neeraj Agarwal, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2023
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomyMatthew D Ho, Anna J Black, Homayoun Zargar, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1E David Crawford, Alan H Bryce, Maha H Hussain, et al.
The Journal of Urology|February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional CohortPeter S Kirk, Yair Lotan, Homayoun Zargar, et al.
World Journal of Urology|August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
BJU International|November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosisFrancesco Soria, Peter C Black, Adrian S Fairey, et al.
The Journal of Urology|August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder CancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
Lancet (London, England)|July 7, 2018
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trialDipen J Parekh, Isildinha M Reis, Erik P Castle, et al.
The Journal of Urology|September 25, 2019
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year FollowupVivek Venkatramani, Isildinha M Reis, Erik P Castle, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2Alan H Bryce, E David Crawford, Neeraj Agarwal, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2023
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomyMatthew D Ho, Anna J Black, Homayoun Zargar, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1E David Crawford, Alan H Bryce, Maha H Hussain, et al.
The Journal of Urology|February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional CohortPeter S Kirk, Yair Lotan, Homayoun Zargar, et al.
World Journal of Urology|August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
Pageof 22